Merck inaugurates its Global Capability Centre in Bengaluru, enhancing digital innovation and collaboration across its global ...
This morning Merck took a difficult and necessary step in trying to wring cost savings out of its $41 billion purchase of Schering-Plough: closing research labs and manufacturing plants. Such closures ...
The new outfit, called Saturnus Bio, was announced today by Merck KGaA, and will focus on developing medicines for rare ...
The proposed acquisition will be the company’s biggest deal in more than a decade and represents an early move by new CEO Kai ...
For good or ill, Merck will have Peter S. Kim to thank for its future drug pipeline. Kim, a 42-year-old professor at the Massachusetts Institute of Technology, will soon head Merck's internal research ...
The Nature Index tracks primary research articles from 145 natural-science and health-science journals, chosen based on reputation by an independent group of researchers. The Nature Index provides ...
When rumors started swirling late last week that Roger Perlmutter, newly appointed Merck research chief, had started cleaning house, industry observers saw it as the proverbial shoe dropping.
Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey BENGALURU (Reuters) - Shares of ...
Merck & Co Inc. MRK on Monday said its investigational therapy tulisokibart achieved the primary endpoint in a Phase 3 study ...
In work on a tumor-cell inhibitor, chemists in Merck’s technology enabled synthesis (TES) group in West Point, Pa., found that microwave chemistry—they use Biotage instruments—has not only sped up ...
Whitehouse Station, NJ - Merck is suing Impax Laboratories, a pharmaceutical company that specializes in generic drugs, to prevent the company from selling a copycat version of Vytorin, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results